buy at this opportunity
JNJ fxxx up pcyc. pcyc could have been a 60 billion dollar co. instead they settle at 20 billions. bad deal. you better off get 100% of the whole pie than taking 15%. Risk all to win big. Thus the sell off today is the market expressing its displeasure of the deal. Expect this #$%$ to dump to 52 wk low.
This junk co made a lot of people lose lots of money from the ipo including myself.
I just can't believe that insiders have no confidence at all with nonstop selling. IPO lockup was released early too. Wall street crooks pumped it up to dump for the past two days combining with short covering.
The company has a fraud structure that no active investors can kick out the ceo n management and sell to bidu or baba at a premium. All investors can do is to salivate over the value and dream about it for the foreseeable future. It has been dead for 15 years. Get out now n Save your time n money. Most of the longs already threw in the towels and left for good. The management is full of imbeciles and birds.
I have been pounding on the table for blue since 80s. market potential of 100 billions for sickle cell in us and 30 billions for thalassemia in eu is crazy. I missed out on the big run.
the technicals have changed for postitive suddenly today. Look for gap up to 60 plus now. This is a wall street crooks' game. Got to play with the crooks.
CART-T cos are falling out of favor for hedge funds. These treatments are years away from FDA approval. They will come back when more positive data comes out with positive psychology. The psychology has shifted. Biologic and traditional drug stocks are where to go now in biotech. rcpt, espr, aldr and generics such as act vrx lci akrx myl
Enbrel ra US market sales is 4.5 billions in 2014. with EU and the world they make 10 plus billions. amgn bought immune at 4 billions price tag. It more than made up for it. Just like Gild's buy of vrus at 10 billions. They are the greatest buys of the biotech in history. aldr has the potential for it. buyout is at least 5 billions.
lets say that they grabbed a 10 % of the shares of the market. Rev will be 3 billions. market cap should be 20 billions within 2-3 years like alxn.
worldwide Market opportunities of RA plus Migraine are enormous at 20 plus and 12 billions. This company should command a market cap of 5 billions easily now. Share price of 100 in the next 3 months easily. It does not happen overnight for sure.